Final answer:
Pharmacists are generally required to report prescriptions that cause serious injury or death, with specific regulations varying by jurisdiction.
Step-by-step explanation:
True or false. Situations in which a prescription causes serious injury or death must be reported to the Board by the pharmacist in charge. This statement is generally true; however, laws and regulations might differ by jurisdiction. In the context of the United States, after a New Drug Application (NDA) approval, the drug sponsor must monitor and report adverse drug experiences to the FDA.
This includes reporting unexpected serious and fatal adverse drug events within 15 days. Additionally, whereas adverse drug event reporting for consumers and health professionals is voluntary through the MedWatch program, pharmacists may have mandatory reporting obligations to their State Board of Pharmacy or other regulatory bodies when they discern that a prescription has caused serious harm or death. Such reporting ensures continuous monitoring of the safety and efficacy of drugs post-approval, allowing for timely intervention when public health is at risk. It’s important for the pharmacist in charge to be aware of their specific state's regulations.